Robert A. Bradway is Amgen’s chairman and chief executive officer, having been named to those positions in January 2013 and May 2012 respectively. He joined the company in 2006 and served as vice president of Operations Strategy, executive vice president, chief financial officer, and president and chief operating officer before assuming his current positions. Bradway was previously a managing director at Morgan Stanley in London where, beginning in 2001, he had responsibility for the firm’s banking department and corporate finance activities in Europe. Bradway is a member of the board of directors of The Boeing Company, the W. M. Keck Foundation, the Pharmaceutical Research and Manufacturers of America (PhRMA), and is a member of the American Heart Association CEO Roundtable. He also serves on the board of trustees of the University of Southern California. Bradway holds a bachelor’s degree in biology from Amherst College and a master’s degree in business administration from Harvard University.
